The immune system is active in breast cancer, playing a dual role in tumor progression and in immune surveillance. Infiltrating immune cells are both prognostic and predictive of response to standard breast cancer therapies.
|Original language||English (US)|
|Journal||ONCOLOGY (United States)|
|State||Published - May 15 2015|
ASJC Scopus subject areas
- Cancer Research